Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab
Titel:
Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab
Auteur:
Arnold, D. Fuchs, C.S. Tabernero, J. Ohtsu, A. Zhu, A.X. Garon, E.B. Mackey, J.R. Paz-Ares, L. Baron, A.D. Okusaka, T. Yoshino, T. Yoon, H.H. Das, M. Ferry, D. Zhang, Y. Lin, Y. Binder, P. Sashegyi, A. Chau, I.